Abstract
New technologies for the treatment of aortic stenosis are evolving to minimise risk and treat an increasingly comorbid population. The sutureless Perceval Valve is one such alternative. Whilst short-term data are promising, there have been limited mid-term outcomes until now. This is the largest systematic review and meta-analysis to evaluate mid-term outcomes in the Perceval Valve in isolation.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
